Evidence map›Paper›PMID 28174730›Full record

ArticleCellular and molecular gastroenterology and hepatology2016

Inhibitors of Arg-Gly-Asp-Binding Integrins Reduce Development of Pancreatic Fibrosis in Mice.

Barbara Ulmasov, Brent A Neuschwander-Tetri, Jinping Lai, Vladimir Monastyrskiy, Trisha Bhat, Matthew P Yates, Jonathan Oliva, Michael J Prinsen, Peter G Ruminski, David W Griggs

Abstract read
In one paragraph

Article in Cellular and molecular gastroenterology and hepatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Using Integrin αInternational journal of radiation oncology, biology, physics · 2025
    Article
  3. Review
  4. Article
  5. CWHM-12, an Antagonist of Integrin-Mediated Transforming Growth Factor-Beta Activation Confers Protection During EarlyJournal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2022
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Emerging strategies to disrupt the central TGF-β axis in kidney fibrosis.Translational research : the journal of laboratory and clinical medicine · 2019
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Targeting αv Integrins in Pancreatic Fibrosis: Progress in Resolving the Scar.Cellular and molecular gastroenterology and hepatology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Barbara UlmasovDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Saint Louis University, Saint Louis, Missouri.
Brent A Neuschwander-TetriDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Saint Louis University, Saint Louis, Missouri.
Jinping LaiDepartment of Pathology, Saint Louis University, Saint Louis, Missouri.
Vladimir MonastyrskiyDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Saint Louis University, Saint Louis, Missouri.
Trisha BhatDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Saint Louis University, Saint Louis, Missouri.
Matthew P YatesCenter for World Health and Medicine, Saint Louis University, Saint Louis, Missouri.
Jonathan OlivaCenter for World Health and Medicine, Saint Louis University, Saint Louis, Missouri.
Michael J PrinsenCenter for World Health and Medicine, Saint Louis University, Saint Louis, Missouri.
Peter G RuminskiCenter for World Health and Medicine, Saint Louis University, Saint Louis, Missouri.
David W GriggsCenter for World Health and Medicine, Saint Louis University, Saint Louis, Missouri.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND &

aimsPancreatic stellate cells (PSCs) regulate the development of chronic pancreatitis (CP) and are activated by the cytokine transforming growth factor β (TGFB). Integrins of the αv family promote TGFB signaling in mice, probably by interacting with the Arg-Gly-Asp (RGD) sequence of the TGFB latency-associated peptide, which frees TGFB to bind its cellular receptors. However, little is known about the role of integrins in the development of CP. We investigated the effects of small-molecule integrin inhibitors in a mouse model of CP.

methodsWe induced CP in C57BL/6 female mice by repeated cerulein administration. An active RGD peptidomimetic compound (Center for World Health and Medicine [CWHM]-12) was delivered by continuous infusion, starting 3 days before or 5 days after cerulein administration began. Pancreata were collected and parenchymal atrophy, fibrosis, and activation of PSCs were assessed by histologic, gene, and protein expression analyses. We measured CWHM-12 effects on activation of TGFB in co-culture assays in which rat PSC cells (large T immortalized cells [LTC-14]) activate expression of a TGFB-sensitive promoter in reporter cells.

resultsPancreatic tissues of mice expressed messenger RNAs encoding subunits of RGD-binding integrins. Cerulein administration increased expression of these integrins, altered pancreatic cell morphology, and induced fibrosis. The integrin inhibitor CWHM-12 decreased acinar cell atrophy and loss, and substantially reduced fibrosis, activation of PSCs, and expression of genes regulated by TGFB. CWHM-12 also reduced established fibrosis in mice and blocked activation of TGFB in cultured cells.

conclusionsBased on studies of a mouse model of CP and cultured PSCs, integrins that bind RGD sequences activate PSCs and promote the development of pancreatic fibrogenesis in mice. Small-molecule antagonists of this interaction might be developed for treatment of pancreatic fibrotic diseases.

Indexed as

Col1a1, collagen type I α1CP, chronic pancreatitisCTGF, connective tissue growth factorCWHM, Center for World Health and MedicineDMEM, Dulbecco's modified Eagle mediumDMSO, dimethyl sulfoxideECM, extracellular matrixFBS, fetal bovine serumIC50, median inhibitory concentrationInflammationLAP, latency-associated peptideLTC-14, large T immortalized cellsMLEC, mink lung epithelial cellMMP, matrix metallopeptidasemPSC, mouse pancreatic stellate cellmRNA, messenger RNAPancreasPBS, phosphate-buffered salinePCR, polymerase chain reactionPeptidomimeticPSC, pancreatic stellate cellp-SMAD, phosphorylated SMADRGD, arginine-glycine-aspartic acidSignal TransductionTGFB, transforming growth factor βα-SMA, α-smooth muscle actin

Identifiers

PMID28174730
PMCPMC5042566

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.